BWX Valuation
Is BWZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of BWZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: BWZ (€0.12) is trading below our estimate of fair value (€0.19)
Significantly Below Fair Value: BWZ is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for BWZ?
Other financial metrics that can be useful for relative valuation.
What is BWZ's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | AU$40.00m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.1x |
Enterprise Value/EBITDA | -4.4x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does BWZ's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 3.3x | ||
A353190 Hurum | 0.5x | n/a | ₩40.1b |
A014100 Medience | 0.6x | n/a | ₩38.3b |
LSL LSL Pharma Group | 5.1x | n/a | CA$45.5m |
531412 Radix Industries (India) | 6.9x | n/a | ₹2.4b |
BWZ BWX | 0.2x | 6.3% | €40.0m |
Price-To-Sales vs Peers: BWZ is good value based on its Price-To-Sales Ratio (0.2x) compared to the peer average (6.9x).
Price to Earnings Ratio vs Industry
How does BWZ's PE Ratio compare vs other companies in the European Personal Products Industry?
Price-To-Sales vs Industry: BWZ is good value based on its Price-To-Sales Ratio (0.2x) compared to the European Personal Products industry average (1.2x).
Price to Sales Ratio vs Fair Ratio
What is BWZ's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 0.2x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate BWZ's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.